Biotech Firm Faces Leadership Shakeup GlycoMimetics, a Maryland-based biotech company, is undergoing major changes as five board members and top executives, including the CEO and CFO, resign. These changes coincide with the termination of a key licensing agreement with Apollomics, adding to the firm's ongoing financial and operational challenges.12